Biogen slashes 2015 forecast as MS drug sales disappoint
 

Biogen slashes 2015 forecast as MS drug sales disappoint
(Reuters) - Sales of Biogen Inc's roster of multiple sclerosis ***** failed to meet analysts' expectation, prompting the company to slash its full-year profit and sales forecast.
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...2o:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...2o:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/0tGxPOolpNw